CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 15,330 shares, a decline of 81.3% from the April 15th total of 82,061 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 2,095,890 shares, the short-interest ratio is currently 0.0 days.

CV Sciences Trading Up 1.0%

Shares of CV Sciences stock traded up $0.00 during mid-day trading on Wednesday, hitting $0.03. 653,813 shares of the stock were exchanged, compared to its average volume of 1,082,421. CV Sciences has a 12 month low of $0.02 and a 12 month high of $0.10. The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.04. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.03 and a quick ratio of 0.21.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.